Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Huys

Showing results (181-190 of 206) with videos related to

Pageof 21
Sort By:
Frontiers in Medicine|June 2, 2020
Risks in Antibiotic Substitution Following Medicine Shortage: A Health-Care Failure Mode and Effect Analysis of Six European HospitalsNenad Miljković, Brian Godman, Eline van Overbeeke, et al.
Frontiers in Oncology|December 16, 2022
What matters most to patients with multiple myeloma? A Pan-European patient preference studyRosanne Janssens, Tamika Lang, Ana Vallejo, et al.
The Journal of Biological Chemistry|May 30, 2002
kappa-Hefutoxin1, a novel toxin from the scorpion Heterometrus fulvipes with unique structure and function. Importance of the functional diad in potassium channel selectivityKellathur N Srinivasan, Vaithiyalingam Sivaraja, Isabelle Huys, et al.
The Patient|March 4, 2021
Patient Preferences in Rare Diseases: A Qualitative Study in Neuromuscular Disorders to Inform a Quantitative Preference StudyA Cecilia Jimenez-Moreno, Eline van Overbeeke, Cathy Anne Pinto, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 2, 2021
A comprehensive review on non-clinical methods to study transfer of medication into breast milk - A contribution from the ConcePTION projectNina Nauwelaerts, Neel Deferm, Anne Smits, et al.
Frontiers in Pharmacology|September 4, 2023
How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to actionRosanne Janssens, Liese Barbier, Mireille Muller, et al.
Frontiers in Public Health|February 26, 2021
Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer PatientsIlaria Durosini, Rosanne Janssens, Reinhard Arnou, et al.
Frontiers in Pharmacology|October 3, 2022
How to balance valuable innovation with affordable access to medicines in Belgium?Steven Simoens, Khadidja Abdallah, Liese Barbier, et al.
Frontiers in Medicine|July 23, 2021
Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative StudyRosanne Janssens, Tamika Lang, Ana Vallejo, et al.
Wellcome Open Research|August 16, 2021
A study protocol for quantifying patient preferences in neuromuscular disorders: a case study of the IMI PREFER ProjectAura Cecilia Jimenez-Moreno, Cathy Anne Pinto, Bennett Levitan, et al.
Pageof 21

Showing results (181-190 of 206) with videos related to

Sort By:
Pageof 21
Frontiers in Medicine|June 2, 2020
Risks in Antibiotic Substitution Following Medicine Shortage: A Health-Care Failure Mode and Effect Analysis of Six European HospitalsNenad Miljković, Brian Godman, Eline van Overbeeke, et al.
Frontiers in Oncology|December 16, 2022
What matters most to patients with multiple myeloma? A Pan-European patient preference studyRosanne Janssens, Tamika Lang, Ana Vallejo, et al.
The Journal of Biological Chemistry|May 30, 2002
kappa-Hefutoxin1, a novel toxin from the scorpion Heterometrus fulvipes with unique structure and function. Importance of the functional diad in potassium channel selectivityKellathur N Srinivasan, Vaithiyalingam Sivaraja, Isabelle Huys, et al.
The Patient|March 4, 2021
Patient Preferences in Rare Diseases: A Qualitative Study in Neuromuscular Disorders to Inform a Quantitative Preference StudyA Cecilia Jimenez-Moreno, Eline van Overbeeke, Cathy Anne Pinto, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 2, 2021
A comprehensive review on non-clinical methods to study transfer of medication into breast milk - A contribution from the ConcePTION projectNina Nauwelaerts, Neel Deferm, Anne Smits, et al.
Frontiers in Pharmacology|September 4, 2023
How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to actionRosanne Janssens, Liese Barbier, Mireille Muller, et al.
Frontiers in Public Health|February 26, 2021
Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer PatientsIlaria Durosini, Rosanne Janssens, Reinhard Arnou, et al.
Frontiers in Pharmacology|October 3, 2022
How to balance valuable innovation with affordable access to medicines in Belgium?Steven Simoens, Khadidja Abdallah, Liese Barbier, et al.
Frontiers in Medicine|July 23, 2021
Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative StudyRosanne Janssens, Tamika Lang, Ana Vallejo, et al.
Wellcome Open Research|August 16, 2021
A study protocol for quantifying patient preferences in neuromuscular disorders: a case study of the IMI PREFER ProjectAura Cecilia Jimenez-Moreno, Cathy Anne Pinto, Bennett Levitan, et al.
Pageof 21